KRAS and colorectal carcinoma: Drost et al. (Drost et al., 2015) used CRISPR - Cas9 technology to modify the four most common CRC genes (APC, TP53, KRAS, and Smad4) in human intestinal stem cells and select mutated organoids by removing a single growth factor.